Wed, Aug 20, 2014, 8:12 AM EDT - U.S. Markets open in 1 hr 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • watchthedownside watchthedownside Sep 9, 2010 8:19 AM Flag

    From 5/2009 to now, no one wanted this?

    $200mm potential revenue that will only yield $20mm in net income at best.....matters a ton to SNTS at current stock price, but not sure it mattered enough to larger pharma...in fact, probably makes this a $4 or $5 stock vs. a $2 stock

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • After Zegerid, this makes perfect sense. It fits well with Glumetza. It may do unexpectedly well, but even if it doesn't catch on, I doubt if it will be a complete bomb, since it does drop A1c a bit. Also the climate for a heart safe drug (and probably tho unclaimably heart protective) is probably better than it was a year ago.

 
SNTS
31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TASER International Inc.
NasdaqGSTue, Aug 19, 2014 4:00 PM EDT
JA Solar Holdings Co., Ltd.
NasdaqGSTue, Aug 19, 2014 4:00 PM EDT